Lingzhi Wang

7PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 13, 2023
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy.

Xue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun

|Apr 01, 2022
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.

Joline S J Lim, Andrea L A Wong, Samuel G W Ow

|Mar 11, 2022
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies.

Malia Alexandra Foo, Mingliang You, Shing Leng Chan

|Oct 21, 2021
Circular RNAs in cell cycle regulation: Mechanisms to clinical significance.

Wei Xiao, Juan Li, June Hu

|Nov 05, 2020
PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases.

Guowei Kim, Hon Lyn Tan, Raghav Sundar

|Aug 21, 2020
Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma.

Wan Qin Chong, Chwee Ming Lim, Arvind Kumar Sinha

Pageof 2